Loading...
First Round of Abstract Submission Ends: Dec 31, 2026
Extended Early Bird Ends: Sep 28, 2026

Topics

The Organizing Committee welcome abstract submissions on the following topics. Topics of interest for submission include, but are not limited to:

  • Pharmacokinetics and Pharmacodynamics
  • Clinical Pharmacology and Rational Therapeutics
  • Toxicology and Drug Safety Evaluation
  • Pharmacogenomics and Precision Medicine
  • Pediatric and Geriatric Pharmacology
  • Target Identification and Validation
  • Lead Optimization and Structure-Based Drug Design
  • Preclinical Studies and Clinical Trial Strategies
  • Translational Medicine (Bench-to-Bedside Approaches)
  • Biomarkers in Drug Development
  • Novel Drug Delivery Systems
  • Nanomedicine and Nano-carrier Technologies
  • Controlled, Sustained, and Targeted Drug Delivery
  • Liposomal, Injectable, and Implantable Systems
  • 3D Printing and Personalized Dosage Forms
  • Biopharmaceutics Classification System
  • Drug Absorption, Distribution, and Bioavailability
  • Biologics, Biosimilars, and Protein Therapeutics
  • Immunopharmaceuticals and Vaccine Technologies
  • Artificial Intelligence in Drug Discovery
  • Machine Learning for Predictive Toxicology
  • Regulatory Affairs (FDA, EMA, ICH Guidelines)
  • Pharmacovigilance and Drug Safety Monitoring
  • Pharmaceutical Supply Chain and Commercialization
  • Oncology and Targeted Cancer Therapies
  • Cardiovascular and Metabolic Disorders
  • Neuropharmacology and CNS Drug Development
  • Immunopharmacology and Inflammatory Disorders
  • Emerging & Interdisciplinary Approaches
  • Green Pharmacy and Eco-Friendly Manufacturing
  • Future Trends in Precision and Personalized Drug Delivery
  • Other related topic